VeriMomsalix alba/daphnoides/fragilis/purpurea bark extract hamilelikte güvenli mi?
No harmonised reproductive classification in ECHA Annex VI and no SCCS or CIR conclusion identifying reproductive hazard for Salix bark extracts; CIR/SCCS level sources treat salicylates (salicylic acid) separately but willow bark extract itself is not listed as H360/H361. The extract contains salicin (salicylate precursor) which can be systemically converted to salicylic acid, so topical use gives low but measurable exposure depending on concentration and formulation (thus e=1). No credible animal or human reproductive data attributing teratogenicity to willow bark extract were identified in reviewed regulatory sources and peer-reviewed literature.
Related ingredients
Frequently asked questions
- salix alba/daphnoides/fragilis/purpurea bark extract hamilelikte güvenli mi?
- No harmonised reproductive classification in ECHA Annex VI and no SCCS or CIR conclusion identifying reproductive hazard for Salix bark extracts; CIR/SCCS level sources treat salicylates (salicylic acid) separately but willow bark extract itself is not listed as H360/H361. The extract contains salicin (salicylate precursor) which can be systemically converted to salicylic acid, so topical use gives low but measurable exposure depending on concentration and formulation (thus e=1). No credible animal or human reproductive data attributing teratogenicity to willow bark extract were identified in reviewed regulatory sources and peer-reviewed literature.
- salix alba/daphnoides/fragilis/purpurea bark extract emzirirken güvenli mi?
- No regulatory harmonised flag or authoritative safety assessment (SCCS/CIR) indicating reproductive or lactation hazards for Salix bark extracts. Theoretical transfer of small amounts of salicylates into circulation is possible from topical use, but expected to be low with typical cosmetic use; evidence for clinically relevant transfer into breast milk from cosmetic topical willow-bark is lacking.
- salix alba/daphnoides/fragilis/purpurea bark extract bebek cildi için güvenli mi?
- No evidence that willow bark extract is a reproductive toxicant or teratogen in humans or animals in regulatory reviews. However, infants (0–3 yr) have higher dermal absorption per kg and a less mature barrier: if the extract contains measurable salicylates, exposure is plausibly higher (adult e=1 → infant e incremented to 2). There is limited/no infant-specific safety data for topical willow-bark-containing cosmetics.
- VeriMom salix alba/daphnoides/fragilis/purpurea bark extract nasıl puanlıyor?
- VeriMom salix alba/daphnoides/fragilis/purpurea bark extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte salix alba/daphnoides/fragilis/purpurea bark extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.